Damian Marron

Président chez NICOX SA Fortune : 14 887 $ au 31/05/2026

Profil

Damian Marron currently works at Circio Holding ASA, as Chairman from 2020, Cytoseek Ltd., as Non-Executive Chairman, Imophoron Ltd., as Non-Executive Chairman, Indegra Therapeutics Ltd., as Chairman, Onya Therapeutics Ltd., as Chairman, Nicox SA, as Chairman from 2024, Cantargia AB, as Director from 2025, Loxbridge Research LLP, as Director, Agalimmune Ltd., as Director, Resolys Bio, Inc., as Director from 2018, and Treehill Partners, LLC, as Head-Biopharma.
Dr. Marron also formerly worked at Cytheris SA, as Chief Executive Officer, Trophos SA, as Chief Executive Officer, Sangamo Therapeutics France SAS, as Chief Executive Officer & Director from 2013 to 2015, PepGen Ltd., as Chairman, France Biotech Association, as Director, Bone Therapeutics SA, as Independent Non-Executive Director, Theralpha, as Director, Nicox SA, as Executive Vice President-Corporate Development from 2002 to 2008, Orphan Europe SARL, as Manager-Drug Group, Bausch & Lomb (Australia) Pty Ltd., as Head-European Development Business in 2013, Rhone-Poulenc Rorer BV, as Principal from 1991 to 2013, and Glaxo Wellcome Immobilière de Recherche SA, as Principal from 1986 to 2013.
Dr. Marron received his undergraduate degree in 1985 from The University of Liverpool.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
CANTARGIA AB 0,03 %	31/12/2024	63 054 ( 0,03 % )	14 887 $	31/05/2026

Postes actifs de Damian Marron

Sociétés	Poste	Début
CIRCIO HOLDING ASA	Président	29/04/2020
CANTARGIA AB	Directeur/Membre du Conseil	26/05/2021
NICOX SA	Président	16/07/2024
Agalimmune Ltd.	Directeur/Membre du Conseil	-
Cytoseek Ltd.	Président	-
Treehill Partners, LLC	Corporate Officer/Principal	-
Resolys Bio, Inc.	Directeur/Membre du Conseil	01/03/2018
Loxbridge Research LLP	Directeur/Membre du Conseil	-

Anciens postes connus de Damian Marron

Sociétés	Poste	Fin
TXCELL	Directeur Général	28/04/2015
░░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░	-
░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░ ░░░░░ ░░░░ ░░░░░░░░░░░ ░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-
░░░░░░ ░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-